These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17667899)

  • 1. Does growth hormone replacement therapy improve cardiac function?
    Giustina A
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):614-5. PubMed ID: 17667899
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult growth hormone replacement using a fixed graded initiation phase followed by an individualised titration phase: a single centre experience.
    Prague J; Taylor C; Al-Zaman Y; Lecka A; Oguntolu V; Miell J; McGregor A; Aylwin S
    Horm Res; 2007; 68 Suppl 5():204. PubMed ID: 18174748
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment approaches of growth failure.
    Rappaport R
    Pediatr Endocrinol Rev; 2008 Dec; 6(2):257. PubMed ID: 19209477
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cardiovascular disease in Turner syndrome.
    Thomas J; Yetman AT
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1631-41. PubMed ID: 19954324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone therapy in adults: what case managers need to know.
    Birmingham J
    Case Manager; 2001; 12(2):57-63. PubMed ID: 11244404
    [No Abstract]   [Full Text] [Related]  

  • 8. Replacement therapy and cardiovascular diseases.
    Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lies, damn lies and statistics.
    Sonksen PH; McGauley G
    Growth Horm IGF Res; 2005 Jun; 15(3):173-6. PubMed ID: 15878300
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of current growth hormone treatments and future therapies.
    Ross R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFs and aging: is there a rationale for hormone replacement therapy?
    Hoffman AR; Ceda GP
    Growth Horm IGF Res; 2004 Aug; 14(4):296-300. PubMed ID: 15231298
    [No Abstract]   [Full Text] [Related]  

  • 12. Should we treat the somatopause?
    Hoffman AR; Ceda GP
    J Endocrinol Invest; 1999; 22(10 Suppl):4-6. PubMed ID: 10727025
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational therapeutic use of growth hormone.
    López Siguero JP
    J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1169-72. PubMed ID: 16398446
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics in growth, and pituitary tumorigenesis. Preface.
    Dunger DB; Popović-Brkić V
    Horm Res; 2009 Apr; 71 Suppl 2():1. PubMed ID: 19407489
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correction of cardiovascular pathology in men with age-dependent androgen deficiency (review)].
    Ametov AS; Vertkin AL; Morgunov LIu; Arinina EN; Naumov AV
    Ter Arkh; 2007; 79(10):50-3. PubMed ID: 18154146
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults.
    Laron Z
    Growth Horm IGF Res; 2000 Aug; 10(4):230-1. PubMed ID: 11032707
    [No Abstract]   [Full Text] [Related]  

  • 17. Which children should receive growth hormone treatment. Cost-benefit analysis is the key.
    Kelnar CJ
    Arch Dis Child; 2000 Aug; 83(2):176-8. PubMed ID: 10950748
    [No Abstract]   [Full Text] [Related]  

  • 18. Central hypothyroidism and growth hormone treatment: clinical care.
    Lania A; Giavoli C; Ferrante E; Beck-Peccoz P
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):66-70. PubMed ID: 19020390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset growth hormone deficiency: causes, complications and treatment options.
    Mathioudakis N; Salvatori R
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):352-8. PubMed ID: 18594276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment approaches for growth failure.
    Rosenbloom AL
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):48-50. PubMed ID: 18806725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.